{"id":"NCT03176771","sponsor":"Mitsubishi Tanabe Pharma Corporation","briefTitle":"Efficacy and Safety of MT-5199 in Subjects With Tardive Dyskinesia","officialTitle":"A Double-Blind, Randomized, Multicenter, Placebo-Controlled, Parallel, Fixed-Dose Study to Evaluate the Efficacy and Safety of MT-5199 for the Treatment in Patients With Tardive Dyskinesia (J-KINECT)","status":"COMPLETED","phase":"PHASE2","dates":{"start":"2017-06-21","primaryCompletion":"2020-09-29","completion":"2020-09-29","firstPosted":"2017-06-05","resultsPosted":"2023-08-14","lastUpdate":"2023-09-06"},"enrollment":256,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Tardive Dyskinesia"],"interventions":[{"type":"DRUG","name":"MT-5199","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"MT-5199 40 mg (Double-Blind Placebo-Controlled Period)","type":"EXPERIMENTAL"},{"label":"MT-5199 80 mg (Double-Blind Placebo-Controlled Period)","type":"EXPERIMENTAL"},{"label":"Placebo (Double-Blind Placebo-Controlled Period)","type":"EXPERIMENTAL"},{"label":"MT-5199 40 mg (Double-Blind Extension Period)","type":"EXPERIMENTAL"},{"label":"MT-5199 80 mg (Double-Blind Extension Period)","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to evaluate the efficacy and safety of MT-5199 administered once daily for the treatment of Tardive Dyskinesia (TD) symptoms.","primaryOutcome":{"measure":"Change From Baseline in Abnormal Involuntary Movement Scale (AIMS) Total Score (Central Assessment) at Week 6","timeFrame":"Baseline and Week 6","effectByArm":[{"arm":"Placebo (Double-Blind Placebo-Controlled Period)","deltaMin":-0.1,"sd":null},{"arm":"MT-5199 40 mg (Double-Blind Placebo-Controlled Period)","deltaMin":-2.3,"sd":null},{"arm":"MT-5199 80 mg (Double-Blind Placebo-Controlled Period)","deltaMin":-3.7,"sd":null}],"pValues":[{"comp":"OG000 vs OG002","p":"<0.001"},{"comp":"OG000 vs OG001","p":"<0.001"}]},"eligibility":{"minAge":"20 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":4},"locations":{"siteCount":82,"countries":["Japan"]},"refs":{"pmids":["36114799","39186921","38421921"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":84},"commonTop":["Nasopharyngitis","Somnolence","Schizophrenia","Salivary hypersecretion","Insomnia"]}}